Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells

Cell Growth and Differentiation

Volumn 12, Issue 9, 2001, Pages 481-486

  Park, J I ^a   Choi, H S ^a   Jeong, J S ^a   Han, J Y ^a   Kim, I H ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HYDROXYUREA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL;

CELL DIFFERENTIATION; FLAVONOIDS; HUMANS; HYDROXYUREA; IMIDAZOLES; K562 CELLS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES;

EID: 0034789188     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Inhibition of ribonucleotide diphosphate reductase by hydroxyurea
2. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes
3. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
4. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years
5. Cellular effects of hydroxyurea in Hb SC disease
6. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
7. Regulation of c-jun mRNA expression by hydroxyurea in human K562 cells during erythroid differentiation
8. S-phase inhibitors induce vimentin expression in human promonocytic U-937 cells
9. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
10. The MAPK signaling cascade
11. Regulation and function of the JNK subgroup of MAP kinases
12. From receptors to stress-activated MAP kinases
13. Components of a new human protein kinase signal transduction pathway
14. Parallel signal processing among mammalian MAPKs
15. Signal transduction through MAP kinase cascades
16. K562 human erythroleukemia cells demonstrate commitment
17. The response of IL-3 dependent B6UtA bone marrow cells to both erythropoletin and chemical inducers of differentiation
18. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)
19. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
20. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
21. Identification of a novel inhibitor of mitogen activated protein kinase kinase
22. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy
23. A synthetic inhibitor of the mitogen-activated protein kinase cascade
24. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
25. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
26. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
27. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
28. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
29. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line
30. The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase
31. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events
32. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase
33. Transformation of mammalian cells by constitutively active MAP kinase kinase
34. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenecity when expressed in fibroblasts
35. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2
36. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
37. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
38. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells
39. A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts
40. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro
41. Molecular themes in oncogenesis
42. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway
43. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3
44. Activation of p38 MAP kinase pathway by erythropotetin and interleukin-3
45. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4
46. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway
47. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
48. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
49. Nitric oxide generation from hydroxyurea via copper-catalyzed peroxidation and implications for pharmacological actions of hydroxyurea